MA29213B1 - Quinolones a substitution macrolones - amino - Google Patents
Quinolones a substitution macrolones - aminoInfo
- Publication number
- MA29213B1 MA29213B1 MA29930A MA29930A MA29213B1 MA 29213 B1 MA29213 B1 MA 29213B1 MA 29930 A MA29930 A MA 29930A MA 29930 A MA29930 A MA 29930A MA 29213 B1 MA29213 B1 MA 29213B1
- Authority
- MA
- Morocco
- Prior art keywords
- macrolones
- quinolones
- substitution
- amino
- medicine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
L'INVENTION CONCERNE DES COMPOSÉS DE FORMULE (I) OU DES DÉRIVÉS ACCEPTABLES SUR LE PLAN PHARMACEUTIQUE DE CEUX-CI POSSÉDANT UNE ACTIVITÉ ANTI-MICROBIENNE, DES PROCÉDÉS DE PRÉPARATION DE CEUX-CI, DES COMPOSTIONS RENFERMANT CEUX-CI ET L'UTILISATION DE CEUX-CI EN MÉDECINE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0424959A GB0424959D0 (en) | 2004-11-11 | 2004-11-11 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29213B1 true MA29213B1 (fr) | 2008-02-01 |
Family
ID=33523587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29930A MA29213B1 (fr) | 2004-11-11 | 2007-05-22 | Quinolones a substitution macrolones - amino |
Country Status (19)
Country | Link |
---|---|
US (2) | US7718621B2 (fr) |
EP (1) | EP1824870A1 (fr) |
JP (1) | JP2008519788A (fr) |
KR (1) | KR20070085919A (fr) |
CN (1) | CN101098881A (fr) |
AR (1) | AR053311A1 (fr) |
AU (1) | AU2005303961A1 (fr) |
BR (1) | BRPI0517792A (fr) |
CA (1) | CA2587413A1 (fr) |
GB (1) | GB0424959D0 (fr) |
IL (1) | IL182978A0 (fr) |
MA (1) | MA29213B1 (fr) |
MX (1) | MX2007005776A (fr) |
NO (1) | NO20072939L (fr) |
PE (1) | PE20061137A1 (fr) |
RU (1) | RU2007121581A (fr) |
TW (1) | TW200630378A (fr) |
WO (1) | WO2006050942A1 (fr) |
ZA (1) | ZA200703603B (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2772254A3 (fr) | 2003-03-10 | 2015-03-11 | Optimer Pharmaceuticals, Inc. | Nouveaux agents antibactériens |
JP2008540504A (ja) * | 2005-05-10 | 2008-11-20 | グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ | 細菌感染症の処置に有用な4’’アミノ結合マクロライド |
JP2009514918A (ja) * | 2005-11-09 | 2009-04-09 | グラクソ グループ リミテッド | 新規4’’−置換エリスロマイシン誘導体 |
EP1945652A1 (fr) * | 2005-11-09 | 2008-07-23 | Glaxo Group Limited | Macrolones |
ES2445442T3 (es) | 2007-09-14 | 2014-03-03 | Vertex Pharmaceuticals Inc. | Moduladores del regulador de la conductancia transmembrana de la fibrosis quística |
CN105732745A (zh) | 2007-10-25 | 2016-07-06 | 森普拉制药公司 | 大环内酯类抗菌剂的制备方法 |
TW200946109A (en) * | 2008-05-09 | 2009-11-16 | Enanta Pharm Inc | Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides |
EP2365747B1 (fr) | 2008-10-24 | 2018-04-11 | Cempra Pharmaceuticals, Inc. | Procédés de traitement de maladies gastro-intestinales |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
EP2475253B1 (fr) | 2009-09-10 | 2016-10-26 | Cempra Pharmaceuticals, Inc. | Méthodes de traitement du paludisme, de la tuberculose et des maladies à complexe mycobacterium avium (mac) |
CA2799937A1 (fr) | 2010-05-20 | 2011-11-24 | Cempra Pharmaceuticals, Inc. | Procedes de preparation de macrolides et de ketolides et d'intermediaires de ceux-ci |
KR20130120458A (ko) | 2010-09-10 | 2013-11-04 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
CA2868262A1 (fr) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Formulations parenterales pour l'administration d'antibiotiques macrolides |
WO2014152326A1 (fr) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Procédés pour traiter des maladies respiratoires et formulations pour la mise en œuvre de ceux-ci |
US9751908B2 (en) | 2013-03-15 | 2017-09-05 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
CN106589023A (zh) * | 2016-11-22 | 2017-04-26 | 宜昌东阳光药业股份有限公司 | 一种罗红霉素杂质及其合成方法 |
WO2018178041A1 (fr) | 2017-03-30 | 2018-10-04 | F. Hoffmann-La Roche Ag | Nouveaux composés pyrido[2,3-b]indole pour le traitement et la prophylaxie d'une infection bactérienne |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2808070A1 (de) * | 1978-02-24 | 1979-08-30 | Bayer Ag | Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten |
GB0127349D0 (en) | 2001-11-14 | 2002-01-02 | Glaxo Group Ltd | Macrolides |
GB0225384D0 (en) * | 2002-10-31 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
-
2004
- 2004-11-11 GB GB0424959A patent/GB0424959D0/en not_active Ceased
-
2005
- 2005-11-09 PE PE2005001311A patent/PE20061137A1/es not_active Application Discontinuation
- 2005-11-09 MX MX2007005776A patent/MX2007005776A/es unknown
- 2005-11-09 RU RU2007121581/04A patent/RU2007121581A/ru not_active Application Discontinuation
- 2005-11-09 TW TW094139277A patent/TW200630378A/zh unknown
- 2005-11-09 CN CNA2005800463765A patent/CN101098881A/zh active Pending
- 2005-11-09 WO PCT/EP2005/012038 patent/WO2006050942A1/fr active Application Filing
- 2005-11-09 AR ARP050104704A patent/AR053311A1/es not_active Application Discontinuation
- 2005-11-09 EP EP05801894A patent/EP1824870A1/fr not_active Withdrawn
- 2005-11-09 CA CA002587413A patent/CA2587413A1/fr not_active Abandoned
- 2005-11-09 JP JP2007540573A patent/JP2008519788A/ja not_active Withdrawn
- 2005-11-09 BR BRPI0517792-8A patent/BRPI0517792A/pt not_active IP Right Cessation
- 2005-11-09 KR KR1020077012942A patent/KR20070085919A/ko not_active Application Discontinuation
- 2005-11-09 AU AU2005303961A patent/AU2005303961A1/en not_active Abandoned
- 2005-11-09 US US11/719,004 patent/US7718621B2/en not_active Expired - Fee Related
-
2006
- 2006-11-07 US US12/093,145 patent/US20080269146A1/en not_active Abandoned
-
2007
- 2007-05-03 IL IL182978A patent/IL182978A0/en unknown
- 2007-05-04 ZA ZA200703603A patent/ZA200703603B/en unknown
- 2007-05-22 MA MA29930A patent/MA29213B1/fr unknown
- 2007-06-08 NO NO20072939A patent/NO20072939L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101098881A (zh) | 2008-01-02 |
PE20061137A1 (es) | 2006-12-13 |
AR053311A1 (es) | 2007-05-02 |
TW200630378A (en) | 2006-09-01 |
MX2007005776A (es) | 2007-07-16 |
RU2007121581A (ru) | 2008-12-20 |
US20080090773A1 (en) | 2008-04-17 |
EP1824870A1 (fr) | 2007-08-29 |
ZA200703603B (en) | 2008-07-30 |
NO20072939L (no) | 2007-08-08 |
IL182978A0 (en) | 2007-08-19 |
AU2005303961A1 (en) | 2006-05-18 |
WO2006050942A1 (fr) | 2006-05-18 |
US20080269146A1 (en) | 2008-10-30 |
KR20070085919A (ko) | 2007-08-27 |
CA2587413A1 (fr) | 2006-05-18 |
GB0424959D0 (en) | 2004-12-15 |
JP2008519788A (ja) | 2008-06-12 |
US7718621B2 (en) | 2010-05-18 |
BRPI0517792A (pt) | 2008-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29213B1 (fr) | Quinolones a substitution macrolones - amino | |
MA27427A1 (fr) | Composes de benzimidazole-1-yl-thiophene utilises en cancerotherapie | |
MA29550B1 (fr) | Derives de n- (pyridine-2-yl) - sulfonamide | |
NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
MA30207B1 (fr) | Modulateurs des recepteurs de la progesterone a base d'indole sulfonamide | |
MA27692A1 (fr) | Composes derives de benzoxazinone, leur preparation et utilisation comme medicaments | |
TNSN07145A1 (fr) | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique | |
MA30717B1 (fr) | Derives de pyridin-3-yle en tant qu'agents immunomodulateurs | |
MA30718B1 (fr) | Derives de pyridin-4-yle en tant qu'agents immunomodulateurs. | |
MA34655B1 (fr) | Dérivés de 2,3- dihydroimidazo[1,2-c]quinazoléine substitués par un aminoalcool utiles pour traiter des troubles hyperprolifératifs et des maladies associées à l'angiogenèse | |
MA27596A1 (fr) | Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation | |
MA30231B1 (fr) | Derives de benzamides et d'heteroarenes | |
BRPI0510414A (pt) | uso de derivados de quinolina substituìdos para o tratamento de doenças micobacterianas resistentes a fármacos | |
SE0001899D0 (sv) | New compounds | |
AU2002218167A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
BRPI0514661B8 (pt) | antagonistas de vasopressina v1a, composição farmacêutica e uso dos referidos antagonistas | |
TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
BRPI0508107A (pt) | derivados de indazol e composições farmacêuticas contendo os mesmos | |
BRPI0418099A (pt) | compostos, composição farmacêutica, e uso de um composto | |
MA27093A1 (fr) | Derives de sulfonamides, leur preparation et leur application comme medicaments. | |
MA31142B1 (fr) | Derives heteroaryles de pyrrolidinyl et piperdinyl cetones. | |
TNSN06440A1 (fr) | Derives de pyrido-pyrimidine, leur preparation, leur application dans le traitement du cancer |